BioCentury
ARTICLE | Clinical News

UreAB recombinant urease oral vaccine with mucosal adjuvant: Phase II testing for H. pylori is complete.

September 30, 1996 7:00 AM UTC

OraVax Inc. (ORVX), Cambridge, Mass. Product: UreAB recombinant urease oral vaccine with mucosal adjuvant Indication: Prevent peptic ulcers from H. pylori infection Status: ORVX announced that Phase I...